Marshall Wace LLP Purchases New Holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Marshall Wace LLP acquired a new position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 829,945 shares of the medical instruments supplier's stock, valued at approximately $15,752,000. Marshall Wace LLP owned approximately 0.42% of DENTSPLY SIRONA as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently added to or reduced their stakes in the company. Riverview Trust Co purchased a new position in shares of DENTSPLY SIRONA during the fourth quarter valued at $26,000. MassMutual Private Wealth & Trust FSB boosted its position in DENTSPLY SIRONA by 648.4% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier's stock worth $27,000 after acquiring an additional 1,232 shares during the period. UMB Bank n.a. grew its stake in DENTSPLY SIRONA by 60.8% during the 4th quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier's stock valued at $28,000 after acquiring an additional 564 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. increased its holdings in shares of DENTSPLY SIRONA by 700.0% in the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,792 shares of the medical instruments supplier's stock valued at $33,000 after purchasing an additional 1,568 shares during the period. Finally, Signaturefd LLC lifted its position in shares of DENTSPLY SIRONA by 513.3% in the fourth quarter. Signaturefd LLC now owns 4,428 shares of the medical instruments supplier's stock worth $84,000 after purchasing an additional 3,706 shares in the last quarter. 95.70% of the stock is owned by institutional investors and hedge funds.

DENTSPLY SIRONA Stock Performance

XRAY stock traded up $0.43 during mid-day trading on Thursday, reaching $13.71. 2,457,870 shares of the stock traded hands, compared to its average volume of 2,963,456. The firm has a market capitalization of $2.73 billion, a PE ratio of -6.62, a P/E/G ratio of 1.80 and a beta of 0.92. The business has a 50-day moving average of $15.19 and a two-hundred day moving average of $18.41. DENTSPLY SIRONA Inc. has a 52 week low of $12.16 and a 52 week high of $31.00. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72.

DENTSPLY SIRONA Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, April 11th. Shareholders of record on Friday, March 28th were issued a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a yield of 4.67%. The ex-dividend date was Friday, March 28th. DENTSPLY SIRONA's dividend payout ratio (DPR) is currently -14.07%.

Wall Street Analyst Weigh In

Several research analysts have weighed in on XRAY shares. StockNews.com lowered shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a research note on Friday, February 28th. Barrington Research reduced their price objective on DENTSPLY SIRONA from $24.00 to $20.00 and set an "outperform" rating for the company in a research report on Friday, February 28th. Morgan Stanley lowered DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 target price on the stock. in a research report on Tuesday, April 15th. Jefferies Financial Group lowered DENTSPLY SIRONA from a "buy" rating to a "hold" rating and reduced their price target for the company from $30.00 to $20.00 in a report on Thursday, January 23rd. Finally, Evercore ISI reaffirmed an "in-line" rating and set a $20.00 price objective on shares of DENTSPLY SIRONA in a research report on Tuesday, January 7th. Thirteen research analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to MarketBeat.com, DENTSPLY SIRONA presently has a consensus rating of "Hold" and a consensus target price of $22.58.

Insiders Place Their Bets

In related news, Director Gregory T. Lucier acquired 15,142 shares of the stock in a transaction dated Monday, March 3rd. The shares were acquired at an average price of $16.51 per share, for a total transaction of $249,994.42. Following the completion of the purchase, the director now owns 81,971 shares in the company, valued at approximately $1,353,341.21. The trade was a 22.66 % increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 0.52% of the company's stock.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.